The combination of FDG PET/CT and circulating tumor cell (CTC) counts might be a useful tool to monitor response to therapy in breast cancer patients, according to a study published in this month's Journal of Nuclear Medicine.
The nuclear medicine community has been pressuring the U.S. government to develop improved domestic capability for producing these materials to reduce this dependence, said Robert Atcher, PhD, MBA, immediate past president of SNM and director of National Isotope Development Center at Los Alamos National Laboratory in White Rock, N.M., at an opening session of the 240th conference of the American Chemical Society, held this week in Boston.
Written by Manjula Puthenedam
SNM, the American Society of Nuclear Cardiology, the American College of Cardiology and a coalition of medical and national security organizations have urged Sen. Christopher S. "Kit" Bond, R-Mo., to lift a "hold" on the American Medical Isotope Production Act (H.R. 3276), and permit a vote by the U.S. Senate, which passed the U.S. House of Representatives by a vote of 400-17. Several radiologists and nuclear medicine specialists spoke to their concerns if the U.S. continues to rely on foreign sources for medical isotopes.
SNM has recognized the contributions to the field of nuclear medicine and molecular imaging during its 57th annual meeting in Salt Lake City.
SNM has issued guidelines to assist nuclear medicine practitioners in recommending, performing, interpreting and reporting results of hepatobiliary scintigraphy in adults and children.
SNM has issued guidelines to assist healthcare professionals in performance, interpretation and reporting the results of PET/CT bone scans performed with 18F-Fluoride.
SNM has issued guidelines to assist breast imaging practitioners in patient selection, performance, interpretation and reporting for breast scintigraphy with 99mTc-sestamibi breast-specific gamma imaging.
Written by Mary Tierney
GE Healthcare introduced InSite OnWatch at the SNM 2010 annual meeting in Salt Lake City in early June. InSite OnWatch, available with GE’s AssurePoint Rapid and AssurePoint Performance service offerings in the U.S. and Canada, remotely resolves small performance issues and forecasts maintenance on certain larger issues, according to the company.
More than 5,100 physicians, technologists and members of the molecular imaging and nuclear medicine communities gathered in Salt Lake City for SNM's 57th annual meeting last week which featured more than 1,400 scientific papers that represented research and developments worldwide in molecular imaging and nuclear medicine.
A study presented at SNM's 57th annual meeting last week in Salt Lake City showed that dual-tracer SPECT/CT can be a valuable tool for accurately diagnosing and determining treatment for a variety of diabetes-associated foot diseases.
SNM has selected an image presented by Kunihiro Nakada, MD from Hokko Memorial Hospital in Sapporo, Japan, and colleagues, illustrating the potential of hybrid molecular imaging to provide precise data regarding anatomical localization, angiography and metabolism of enlarged parathyroid gland, as the 2010 Image of the Year from more than 1,500 studies presented last week during its annual meeting in Salt Lake City.
Written by Mary Tierney
GE Healthcare presented results of a phase 1 study of [18F]FACBC at the annual meeting of SNM last week in Salt Lake City.
Written by Mary Tierney
GE Healthcare last week at the annual meeting of SNM in Salt Lake City, announced three pieces of radiopharmacy infrastructure—a cyclotron for large-scale radiotracer production, the expansion of its radiopharmacy chemistry synthesis portfolio and a PET radiotracer production infrastructure.
Written by Mary Tierney
Siemens Healthcare introduced Iterative Reconstruction in Image Space (IRIS) CT technology for molecular imaging at the SNM annual meeting in Salt Lake City last week. By adding IRIS CT to the TrueV and HD technologies already available with Siemens Biograph family of PET/CT scanners, the company said users can achieve about 60 percent dose reduction.
Written by Mary Tierney
Lantheus Medical Imaging last week at the SNM Annual Meeting in Salt Lake City reported Phase 1 data for its PET imaging agent, LMI 1195, which is in development for the evaluation of patients at risk of heart failure or sudden cardiac death.
Written by Mary Tierney
Major developments in molecular imaging’s ability to detect and facilitate treatment of Alzheimer's disease and prostate cancer were among the key scientific papers highlighted last week at the 57th annual SNM conference in Salt Lake City by Past President Peter S. Conti, MD, PhD. The papers were among many more presented, which included 88 platform sessions with 600 oral presentations and 825 scientific poster presentations.
In a comparative study presented at SNM’s 57th annual meeting in Salt Lake City, researchers showed direct production of technetium-99m using cyclotrons is a potential cost-effective means to alleviate the isotope crisis.
Written by Mary Tierney
Some progress is being made to avert the widespread molybdenum-99 (Mo-99) shortage in the U.S., but it’s not enough in the short term and especially not in the long term, according to Robert Atcher, PhD, MBA, immediate past president of SNM and University of New Mexico/LANL professor of pharmacy, bioscience division at Los Alamos National Laboratory, White Rock, N.M. Atcher spoke to members of the press Monday at the 57th annual meeting of SNM.
Written by Lisa Fratt
SALT LAKE CITY—Combining radiomicrosphere therapy with SPECT/CT may be more effective and lead to fewer complications than conventional planar imaging with a gamma camera, based on research presented at the 57th SNM annual meeting this week.
Written by Lisa Fratt
SALT LAKE CITY—A new radioisotope generator could diversify the number of PET imaging agents, based on research presented at the 57th annual conference of SNM this week.
|